Londoners who have contracted cancer due to asbestos exposure could have their treatment taken away. According to the National Institute for Clinical Excellence, the drug Alimta - the only licensed drug to treat sufferers - is too expensive. Currently Primary Care Trusts provide the medicine according to a postcode lottery. But now they could scrap the drug completely.